Newland Pharmaceutical Co., Ltd. (SHE:301277)
China · Delayed Price · Currency is CNY 12.68
+0.16 (1.28%)
At close: Jan 30, 2026
Newland Pharmaceutical Revenue
Newland Pharmaceutical had revenue of 122.43M CNY in the quarter ending September 30, 2025, a decrease of -12.85%. This brings the company's revenue in the last twelve months to 670.43M, down -4.03% year-over-year. In the year 2024, Newland Pharmaceutical had annual revenue of 726.44M with 11.51% growth.
Revenue (ttm)
670.43M
Revenue Growth
-4.03%
P/S Ratio
7.46
Revenue / Employee
643.41K
Employees
1,042
Market Cap
5.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 726.44M | 75.00M | 11.51% |
| Dec 31, 2023 | 651.44M | 24.07M | 3.84% |
| Jan 1, 2023 | 627.36M | 113.53M | 22.09% |
| Jan 1, 2022 | 513.84M | 80.71M | 18.64% |
| Dec 31, 2020 | 433.12M | 26.60M | 6.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jinhe Biotechnology CO., LTD. | 2.75B |
| Luoxin Pharmaceuticals Group Stock | 2.49B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.74B |
| Hunan Fangsheng Pharmaceutical | 1.68B |
| Bide Pharmatech | 1.27B |
| Zhuhai Rundu Pharmaceutical | 1.19B |
| Tibet Weixinkang Medicine | 1.17B |
| Shanghai Xiao Fang Pharmaceutical | 504.59M |